Milk is the source of high-quality protein, calcium, and other vitamins and minerals. Epidemiologic studies have linked high consumption of milk with risk of metabolic syndrome, T2DM, hypertension and obesity, which are independent risk factors of cardiovascular disease. However, milk contains disaccharide lactose, which may cause gastrointestinal problems in those adults with poor digestion. Recent studies have shown that subjects with intolerance to lactose tend to reduce their consumption of milk. Actually, consumption of 12g lactose (240ml milk) per day produces negligible symptoms in lactose intolerant. Furthermore, a dairy-rich diet could improve lactose intolerance because of colonic adaption to it. Lactose maldigestion would not be a restricting factor in milk intake. In general, the undigested lactose will be fermented by colonic bacteria into hydrogen, carbon dioxide, and short-chain fatty acids (SCFA: acetate, propionate, and butyrate). The SCFAs may have beneficial effects on human glucose and lipid metabolism, and the lactose fermentation may change the intestinal flora profile. But there are few studies evaluating effect of milk intake on health of people with lactose malabsorption or intolerance.This trial intend to study the effect of whole milk on cardio-metabolic risk factors of healthy person with or without lactose maldigestion.
Study Type
INTERVENTIONAL
Purpose
PREVENTION
Masking
NONE
Enrollment
60
intake 250ml full-fat milk per day, do not intake any other dairy products
Huazhong University of Science and Technology
Wuhan, Hubei, China
RECRUITINGChanges in body weight
Time frame: 4 weeks
Change in body composition (body fat mass and lean mass)
Body fat mass and lean mass measured by Bioelectric Impedance Analysis(BIA)
Time frame: 4 weeks
Changes in blood pressure
Systolic Blood Pressure and Diastolic Blood Pressure before and after milk intervention
Time frame: 4 weeks
Changes in blood lipids profile
Fasting plasma Total cholesterol, Low Density Lipoprotein, High Density Lipoprotein and triglycerides before and after milk intervention
Time frame: 4 weeks
Changes in fasting plasma glucose
Time frame: 4 weeks
Changes in fasting plasma insulin
Time frame: 4 weeks
Changes in fasting plasma C-peptide
Time frame: 4 weeks
Changes in Homeostasis Model Assessment of Insulin Resistance(HOMA-IR)
Insulin sensitivity measure derived from fasting glucose and insulin
Time frame: 4 weeks
Changes in pro-inflammatory markers
Fasting plasma C-reactive protein, interleukin-6 and tumor necrosis factor-α before and after milk intervention
Time frame: 4 weeks
Changes in markers of oxidative stress
Fasting plasma MDA, oxidized LDL before and after milk intervention
Time frame: 4 weeks
Biomarkers in urine
Time frame: 4 weeks
Changes in fecal fat excretion
Time frame: 4 weeks
Changes in fecal short chain fatty acids (SCFA)
Fecal acetate, propionate, butyrate before and after milk intervention
Time frame: 4 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.